KM Financial Solutions | UPDATE 1-U.S. to consider expanding Medicare drug price negotiation
17025
post-template-default,single,single-post,postid-17025,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-U.S. to consider expanding Medicare drug price negotiation

UPDATE 1-U.S. to consider expanding Medicare drug price negotiation

WASHINGTON, May 14 (Reuters) – The Trump administration is
considering expanding Medicare’s ability to negotiate the cost
of drugs by giving private payers a role in setting the price of
medicines administered in hospitals and doctors’ offices, Health
and Human Services Secretary Alex Azar said on Monday.

No Comments

Sorry, the comment form is closed at this time.